FR2190414B1 - - Google Patents

Info

Publication number
FR2190414B1
FR2190414B1 FR7320833A FR7320833A FR2190414B1 FR 2190414 B1 FR2190414 B1 FR 2190414B1 FR 7320833 A FR7320833 A FR 7320833A FR 7320833 A FR7320833 A FR 7320833A FR 2190414 B1 FR2190414 B1 FR 2190414B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7320833A
Other versions
FR2190414A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FR2190414A1 publication Critical patent/FR2190414A1/fr
Application granted granted Critical
Publication of FR2190414B1 publication Critical patent/FR2190414B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7320833A 1972-07-01 1973-06-07 Expired FR2190414B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6630172A JPS5512435B2 (fr) 1972-07-01 1972-07-01

Publications (2)

Publication Number Publication Date
FR2190414A1 FR2190414A1 (fr) 1974-02-01
FR2190414B1 true FR2190414B1 (fr) 1976-07-02

Family

ID=13311838

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7320833A Expired FR2190414B1 (fr) 1972-07-01 1973-06-07

Country Status (15)

Country Link
US (1) US3925357A (fr)
JP (1) JPS5512435B2 (fr)
AT (1) AT325206B (fr)
AU (1) AU469986B2 (fr)
BE (1) BE801588A (fr)
CA (1) CA996548A (fr)
CH (1) CH573435A5 (fr)
CS (1) CS168036B2 (fr)
DE (1) DE2332840A1 (fr)
FR (1) FR2190414B1 (fr)
GB (1) GB1386566A (fr)
HU (1) HU166029B (fr)
NL (1) NL7308048A (fr)
PL (1) PL92969B1 (fr)
SE (1) SE402916B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522148U (fr) * 1978-07-29 1980-02-13
AU2002234640B8 (en) * 2001-02-24 2009-11-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xanthine derivative, production and use thereof as a medicament
US20030171424A1 (en) * 2002-03-07 2003-09-11 Lin Ai J. Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en) * 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) * 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
JP5323684B2 (ja) * 2006-05-04 2013-10-23 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 多形体
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP1852108A1 (fr) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Compositions d'inhibiteurs de la DPP IV
JP5769966B2 (ja) * 2007-08-17 2015-08-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｆａｂ関連疾患治療用プリン誘導体
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
EP2326326B1 (fr) * 2008-08-15 2019-10-09 Boehringer Ingelheim International GmbH Inhibiteurs de dpp-4 destinés à l'utilisation dans la cicatrisation des lésions des diabétiques
CN102149407A (zh) 2008-09-10 2011-08-10 贝林格尔.英格海姆国际有限公司 治疗糖尿病和相关病症的组合疗法
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CN107011345A (zh) 2008-12-23 2017-08-04 勃林格殷格翰国际有限公司 有机化合物的盐形式
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
EP2504002B1 (fr) 2009-11-27 2019-10-09 Boehringer Ingelheim International GmbH Traitement de patients diabétiques génotypés par des inhibiteurs de dpp-iv tels que la linagliptine
MX341025B (es) 2010-05-05 2016-08-04 Boehringer Ingelheim Int Gmbh * Terapia de combinacion.
NZ603319A (en) 2010-06-24 2015-04-24 Boehringer Ingelheim Int Diabetes therapy
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
PL2731947T3 (pl) 2011-07-15 2019-07-31 Boehringer Ingelheim International Gmbh Podstawiona dimeryczna pochodna chinazoliny, sposób jej wytwarzania i jej zastosowanie w kompozycjach farmaceutycznych do leczenia cukrzycy typu I i II
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (fr) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh Dérivé de xanthine en tant qu'inhibiteur de la dpp-4 à utiliser dans la modification de l'apport alimentaire et dans la régulation des préférences alimentaires
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
EP4233840A3 (fr) 2016-06-10 2023-10-18 Boehringer Ingelheim International GmbH Combinaisons de linagliptine et de metformine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1026793A (fr) * 1949-08-02 1953-05-04 American Cyanamid Co Procédé de préparation de sels de pénicilline
NL6803062A (fr) * 1967-03-10 1968-09-11
US3557094A (en) * 1968-01-05 1971-01-19 Pfizer & Co C Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) * 1968-09-28 1971-05-15 Takeda Chemical Industries Ltd Verfahren zur herstellung neuer penicilline

Also Published As

Publication number Publication date
PL92969B1 (fr) 1977-04-30
JPS4925121A (fr) 1974-03-06
CS168036B2 (fr) 1976-05-28
FR2190414A1 (fr) 1974-02-01
JPS5512435B2 (fr) 1980-04-02
US3925357A (en) 1975-12-09
HU166029B (fr) 1974-12-28
DE2332840A1 (de) 1974-01-17
AT325206B (de) 1975-10-10
BE801588A (fr) 1973-12-28
NL7308048A (fr) 1974-01-03
SE402916B (sv) 1978-07-24
AU5760073A (en) 1975-01-09
CA996548A (en) 1976-09-07
AU469986B2 (en) 1976-02-26
CH573435A5 (fr) 1976-03-15
GB1386566A (en) 1975-03-12

Similar Documents

Publication Publication Date Title
FR2185011A1 (fr)
JPS48105848U (fr)
JPS48109834U (fr)
CH560400A5 (fr)
BG17219A1 (fr)
BG17397A1 (fr)
NL7308048A (fr)
CH133573A4 (fr)
CH1353173A4 (fr)
CH1773873A4 (fr)
CH494772A4 (fr)
CH559801B5 (fr)
CH560310A5 (fr)
CH560774A5 (fr)
CH562061A5 (fr)
CH562128A5 (fr)
CH562294A5 (fr)
CH563243A5 (fr)
CH563258A5 (fr)
CH563273A5 (fr)
CH563574A5 (fr)
CH563593A5 (fr)
CH563646A5 (fr)
CH565222A5 (fr)
CH565254A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse